Search research articles
Contact Us
Filters
Showing results (11-20 of 54) with videos related to
Page
of 6
Sort By:
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation
Mizuho Asada, Fuka Aizawa, Takahisa Mikami, et al.
Cancer Medicine
|
December 19, 2018
Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database
Naoto Okada, Takahiro Niimura, Yoshito Zamami, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 30, 2025
[Promotion of the appropriate use of antimicrobial agents by utilizing medical big data]
Masayuki Chuma, Mitsuhiro Goda, Hirofumi Hamano, et al.
European Journal of Clinical Pharmacology
|
September 13, 2019
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study
Naoto Okada, Masayuki Chuma, Momoyo Azuma, et al.
Clinical Therapeutics
|
October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study
Naoto Okada, Yuki Izumi, Aki Nakamoto, et al.
Pharmacoepidemiology and Drug Safety
|
September 18, 2018
Development and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levels
Shunsuke Ishida, Kenshi Takechi, Hiroshi Bando, et al.
Acta Medica Okayama
|
August 27, 2020
Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin C
Masayuki Chuma, Masateru Kondo, Yoshito Zamami, et al.
The Journal of Medical Investigation : JMI
|
May 17, 2021
Academic investigators' interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act
Masayuki Chuma, Kenshi Takechi, Kenta Yagi, et al.
Cancer Chemotherapy and Pharmacology
|
September 11, 2019
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
Takumi Sakurada, Sanako Bando, Yoshito Zamami, et al.
Therapeutic Drug Monitoring
|
November 3, 2017
Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients
Masayuki Chuma, Makoto Makishima, Toru Imai, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 54) with videos related to
Sort By:
Page
of 6
Multiple Sclerosis and Related Disorders
|
March 15, 2026
Bile acids as candidate therapies for multiple sclerosis: inverse signal analysis using the FDA adverse event reporting system and preclinical validation
Mizuho Asada, Fuka Aizawa, Takahisa Mikami, et al.
Cancer Medicine
|
December 19, 2018
Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR-ABL inhibitor use by using an adverse drug event reporting database
Naoto Okada, Takahiro Niimura, Yoshito Zamami, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
April 30, 2025
[Promotion of the appropriate use of antimicrobial agents by utilizing medical big data]
Masayuki Chuma, Mitsuhiro Goda, Hirofumi Hamano, et al.
European Journal of Clinical Pharmacology
|
September 13, 2019
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study
Naoto Okada, Masayuki Chuma, Momoyo Azuma, et al.
Clinical Therapeutics
|
October 13, 2021
Impact of Area Under the Concentration-Time Curve on the Prevalence of Vancomycin-Induced Nephrotoxicity in Combination With Tazobactam/Piperacillin or Cefepime: A Single-Institution Retrospective Study
Naoto Okada, Yuki Izumi, Aki Nakamoto, et al.
Pharmacoepidemiology and Drug Safety
|
September 18, 2018
Development and pharmacist-mediated use of tools for monitoring atypical antipsychotic-induced side effects related to blood glucose levels
Shunsuke Ishida, Kenshi Takechi, Hiroshi Bando, et al.
Acta Medica Okayama
|
August 27, 2020
Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin C
Masayuki Chuma, Masateru Kondo, Yoshito Zamami, et al.
The Journal of Medical Investigation : JMI
|
May 17, 2021
Academic investigators' interest in promoting specified clinical trials : Questionnaire survey before and after implementation of the Clinical Trial Act
Masayuki Chuma, Kenshi Takechi, Kenta Yagi, et al.
Cancer Chemotherapy and Pharmacology
|
September 11, 2019
Prophylactic administration of granulocyte colony-stimulating factor in epirubicin and cyclophosphamide chemotherapy for Japanese breast cancer patients: a retrospective study
Takumi Sakurada, Sanako Bando, Yoshito Zamami, et al.
Therapeutic Drug Monitoring
|
November 3, 2017
Relationship Between Initial Vancomycin Trough Levels and Early-Onset Vancomycin-Associated Nephrotoxicity in Critically Ill Patients
Masayuki Chuma, Makoto Makishima, Toru Imai, et al.
Page
of 6